PD-L1 Targeting Immune-Microbubble Complex Enhances Therapeutic Index in Murine Colon Cancer Models

• Egile Nagusiak: Daehyun Kim (Egilea), Seung Soo Lee (Egilea), Hyungwon Moon (Egilea), So Yeon Park (Egilea), Hak Jong Lee (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2020-12-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Cancer immunotherapy has revolutionized the way different neoplasms are treated. Among the different variations of cancer immunotherapy, the checkpoint inhibitors targeting the programmed cell death protein 1 (PD-1)/programmed death-ligand 1 (PD-L1) axis have been validated and are currently used in...